IL-12 receptor deficiency revisited: IL-23-mediated signaling is also impaired in human genetic IL-12 receptor β1 deficiency

European Journal of Immunology

Volumn 33, Issue 12, 2003, Pages 3393-3397

  Hoeve, Marieke A ^a   de Boer, Tjitske ^a   Langenberg, Dennis M L ^a   Sanal, Ozden ^b   Verreck, Frank A W ^a   Ottenhoff, Tom H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cell mediated immunity; IFN induction; IL 12R 1 deficiency; Interleukin 23; Mycobacterial infection

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; GENE DELETION; GENETIC DISORDER; HOMOZYGOSITY; HUMAN; IMMUNE DEFICIENCY; INFECTION SENSITIVITY; NONSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-18; INTERLEUKIN-23; INTERLEUKIN-23 SUBUNIT P19; INTERLEUKINS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0346752089     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324343     Document Type: Article

References (23)

1. Ottenhoff, T. H., Verreck, F. A., Lichtenauer-Kaligis, E. G., Hoeve, M. A., Sanal, O. and Van Diesel, J. T., Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat. Genet. 2002. 32: 97-105.
2. Lichtenauer-Kaligis, E. G., de Boer, T., Verreck, F. A., van Voorden, J., Hoeve, M. A., van Diesel, J., Sanal, O. and Ottenhoff, T. H., Severe Mycobacterium bovis BCG infections in a large series of novel IL-12 receptor beta 1 deficient patients and evidence for the existence of partial IL-12 receptor beta 1 deficiency. Eur. J. Immunol. 2003. 33: 59-69.
3. Fieschi, C., Dupuis, S., Catherinot, E., Feinberg, J., Bustsmante, J., Breiman, A., Altare, F., Baretto, R, Le Deist, F., Kayal, S. et al., Low penetrance, broad resistance and a favorable outcome of interleukin 12 receptor β1 deficiency: medical and immunological implications. J. Exp. Med. 2003. 197: 527-535.
4. Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, F. et al., Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000. 13: 715-725.
5. Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., Pflanz, S., Zhang, R., Singh, K. P., Vega, F. et al., A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 2002. 168: 5699-5708.
6. Cue, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T. et al., Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003. 421: 744-748.
7. Verhagen, C. E., de Boer, T., Smits, H. H., Verreck, F. A., Wierange, E. A., Kurimoto, M., Lammas, D. A., Kumararatne, D. S., Sanal, O., Kroon, F. P. et al., Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rβ1): evidence for an IL- 12Rβ1-independent pathway of IL-12 responsiveness in human T cells. J. Exp. Med. 2000. 192: 517-528.
8. Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G. and Glimcher, L. H., A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000. 100: 655-669.
9. Lighvani, A. A., Frucht, D. M., Jankovic, D., Yamane, H., Aliberti, J., Hissong, B. D., Nguyen, B. V., Gadina, M., Sher, A., Paul, W. E. and O'Shea, J. J., T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. USA 2001. 98: 15137-15142.
10. Kubin, M., Kamoun, M. and Trinchieri, G., Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J. Exp. Med. 1994. 180: 211-222.
11. Nakanishi, K., Yoshimoto, T., Tsutsui, H. and Okamura, H., Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 2001. 19: 423-474.
12. de Jong, R., Altars, F., Haagen, I. A., Elferink, D. G., de Boer, T., Breda Vriesman, P. J., Kabel, P. J., Draaisma, J. M., Van Diesel, J. T., Kroon, F. P. et al., Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 1998. 280: 1435-1438.
13. Van de Vosse, E., Lichtenauer-Kaligis, E. G., van Dissel, J. T. and Ottenhoff T. H., Genetic variations in the interleukin-12/ interleukin-23 receptor (β1) chain, and implications for IL-12 and IL-23 receptor structure and function. Immunogenetics 2003. 54: 817-829.
14. Cleary, A. M., Tu, W., Enright, A., Giffon, T., Dewaal-Malefyt, R., Gutierrez, K. and Lewis, D. B., Impaired accumulation and function of memory CD4 T cells in human IL-12 receptor beta 1 deficiency. J. Immunol. 2003. 170: 597-603.
15. Decken, K., Kohler, G., Palmer-Lehmann, K., Wunderlin, A., Mattner, F., Magram, J., Gately, M. K. and Alber, G., Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect. Immun. 1998. 66: 4994-5000.
16. Brombacher, F., Dorfmuller A., Magram, J., Dai, W. J., Kohler, G., Wunderlin, A., Palmer-Lehmann, K., Gately, M. K. and Alber, A., IL-12 is dispensable for innate and adaptive immunity against low doses of Listeria monocytogenes. Int. Immunol. 1999. 11: 325-332.
17. Wu, C., Wang, X, Gadina, M., O'Shea, J. J., Presky D. H. and Magram, J., IL-12 receptor beta 2 (IL-12R beta 2)-deficient mice are defective in IL-12-mediated signaling despite the presence of high affinity IL-12 binding sites. J. Immunol. 2000. 165: 6221-6228.
18. Cooper, A. M., Kipnis, A., Turner, J., Magram, J., Ferrante, J. and Orme, I. M., Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J. Immunol. 2002. 168: 1322-1327.
19. Elkins, K. L., Cooper, A., Colombini, S. M., Cowley, S. C. and Kieffer, T. L., In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70. Infect Immun. 2002. 70: 1936-1948.
20. Belladonna, M. L., Renauld, J. C., Bianchi, R., Vacca, C., Fallsrino, F., Orabona, C., Fioretti, M. C., Grohmann, U. and Puccetti, P., IL-23 and IL-12 have overlapping, but distinct, effects on murine dendritic cells. J. Immunol. 2002. 168: 5448-5454.
21. Wiekowski, M. T., Leach, M. W., Evans, E. W., Sullivan, L., Chen, S. C., Vassileva, G., Bazan, J. F., Gorman, D. M., Kastelein, R. A., Narula, S. and Lira, S. A., Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J. Immunol. 2001. 166: 7563-7570.
22. Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J. and Gurney, A. L., Interleukin 23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin 17. J. Biol. Chem. 2002. 278: 1910-1914.
23. Happel, K. I., Zheng, M., Young, E., Quinton, L. J., Lockhart, E., Ramsay, A. J., Shellito, J. E., Schurr, J. R., Bagby, G. J., Nelson, S. and Kolls, J. K., Cutting Edge: Roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 2003. 170: 4432-4436.